Cargando…
Saporin-S6: A Useful Tool in Cancer Therapy
Thirty years ago, the type 1 ribosome-inactivating protein (RIP) saporin-S6 (also known as saporin) was isolated from Saponaria officinalis L. seeds. Since then, the properties and mechanisms of action of saporin-S6 have been well characterized, and it has been widely employed in the construction of...
Autores principales: | Polito, Letizia, Bortolotti, Massimo, Mercatelli, Daniele, Battelli, Maria Giulia, Bolognesi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813907/ https://www.ncbi.nlm.nih.gov/pubmed/24105401 http://dx.doi.org/10.3390/toxins5101698 |
Ejemplares similares
-
High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin
por: Bortolotti, Massimo, et al.
Publicado: (2016) -
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells
por: Polito, Letizia, et al.
Publicado: (2017) -
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy
por: Polito, Letizia, et al.
Publicado: (2011) -
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents
por: Bortolotti, Massimo, et al.
Publicado: (2023) -
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018)